GlassScriptPhysician profile
Andre Paul Marshall
NPI 1932360880
$8,443.88
in general payments reported to CMS, 2019-2025
16 companies · $1,169 in 2025
The $1,169 reported for 2025 was more than what 76% of Plastic Surgery providers received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,717 · 2022: $1,252 · 2023: $2,819 · 2024: $1,487 · 2025: $1,169.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,684 · Travel and Lodging: $1,639 · Consulting Fee: $152.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,683.99 |
| Travel and Lodging | $1,638.63 |
| Consulting Fee | $152.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $2,763.43 | 2022-2025 | |
| Tela Bio, INC. | $2,484.68 | 2022-2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex), Ovitex 2s |
| Allergan, INC. | $1,163.93 | 2019-2022 | |
| Tepha INC | $543.28 | 2019 | |
| Sientra, INC. | $298.98 | 2022 | |
| Microaire Surgical Instruments LLC | $260.76 | 2023-2024 | Pal |
| Surgical Specialties Corporation (US), INC. (Dba Corza Medical) | $228.07 | 2022 | |
| Solta Medical, A Division of Bausch Health US, LLC | $166.67 | 2024 | |
| Axogen | $150.00 | 2024 | Axoguard Nerve Connector, Avance Nerve Graft, Axoguard Nerve Protector |
| Mentor Worldwide LLC | $116.25 | 2019 | |
| Davol INC. | $79.16 | 2023 | Phasix Mesh |
| Motiva USA, LLC | $75.00 | 2025 | |
| Integra Lifesciences Corporation | $40.30 | 2025 | Integra, Surgimend, Integra Dermal Regeneration Template |
| Vioptix INC | $33.69 | 2019 | |
| Revance Therapeutics, INC. | $21.71 | 2024 | Daxxify |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Galderma Laboratories, L.P. | $17.97 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andre Marshall listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.